Research Article

Spleen Stiffness Performance in the Noninvasive Assessment of Gastroesophageal Varices after Transjugular Intrahepatic Portosystemic Shunts

Table 2

Diagnostic performance of SS, LS, SS/LS, LSPS, PH risk score, PSR, and varices risk score for evaluating the severity of GEVs in the post-TIPS short-term follow-up.

CharacteristicAUC (%)Cutoff valueSensitivity (%)Specificity (%)Youden index

Mild GEVs
 SS58.530.350.072.20.2
 LS54.713.635.983.30.2
 SS/LS55.03.625.9100.00.3
 LSPS60.93.942.488.90.3
 PH risk score64.63.559.372.20.3
 PSR59.43.855.672.20.3
 Varices risk score64.12.342.489.90.3
Moderate GEVs
 SS65.530.659.470.80.3
 LS53.610.476.744.20.2
 SS/LS59.84.032.193.80.3
 LSPS65.14.853.681.60.4
 PH risk score68.85.264.373.50.4
 PSR38.010.218.893.90.1
 Varices risk score67.13.246.495.90.4
Severe GEVs
 SS73.931.983.367.60.5
 LS60.08.642.984.00.3
 SS/LS69.34.150.088.60.4
 LSPS57.32.583.346.50.3
 PH risk score62.65.083.359.20.4
 PSR36.726.016.7100.00.1
 Varices risk score67.72.283.364.80.5

SS: spleen stiffness; LS: liver stiffness; SS/LS: spleen stiffness-to-liver stiffness ratio; LSPS: liver stiffness spleen-diameter-to-platelet-ratio score; PH risk score: portal hypertension risk score; PSR: platelet count-to-spleen diameter ratio; GEVs: gastroesophageal varices; TIPS: transjugular intrahepatic portosystemic shunt; AUC: areas under the receiver operating characteristic curve. AUC of SS was statistically compared with AUC of LS, SS/LS, LSPS, PH risk score, PSR, and varices risk score, respectively, in the same GEVs stage ().